These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16999191)

  • 21. Regulation of aromatase expression in breast cancer tissue.
    Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
    Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP7B1-mediated metabolism of dehydroepiandrosterone and 5alpha-androstane-3beta,17beta-diol--potential role(s) for estrogen signaling.
    Pettersson H; Holmberg L; Axelson M; Norlin M
    FEBS J; 2008 Apr; 275(8):1778-89. PubMed ID: 18331353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of hormone carcinogenesis: evolution of views, role of mitochondria.
    Chen JQ; Brown TR; Yager JD
    Adv Exp Med Biol; 2008; 630():1-18. PubMed ID: 18637481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotoxicity of steroidal estrogens.
    Russo J; Russo IH
    Trends Endocrinol Metab; 2004 Jul; 15(5):211-4. PubMed ID: 15223050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
    Yang XR; Pfeiffer RM; Garcia-Closas M; Rimm DL; Lissowska J; Brinton LA; Peplonska B; Hewitt SM; Cartun RW; Mandich D; Sasano H; Evans DB; Sutter TR; Sherman ME
    Cancer Res; 2007 Nov; 67(21):10608-17. PubMed ID: 17968031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menopausal hormone therapy and breast cancer phenotype: does dose matter?
    Garwood ER; Kumar AS; Shim V
    Ann Surg Oncol; 2008 Sep; 15(9):2526-32. PubMed ID: 18618187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
    Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
    Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
    Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE
    J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
    Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
    [No Abstract]   [Full Text] [Related]  

  • 30. Aromatase in the central nervous system.
    Naftolin F; MacLusky NJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3274s-3276s. PubMed ID: 7083185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apple phytochemical extracts inhibit proliferation of estrogen-dependent and estrogen-independent human breast cancer cells through cell cycle modulation.
    Sun J; Liu RH
    J Agric Food Chem; 2008 Dec; 56(24):11661-7. PubMed ID: 19053381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells.
    Hodges-Gallagher L; Valentine CD; Bader SE; Kushner PJ
    Breast Cancer Res Treat; 2007 Nov; 105(3):297-309. PubMed ID: 17186358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells.
    Altiok N; Koyuturk M; Altiok S
    Breast Cancer Res Treat; 2007 Nov; 105(3):247-54. PubMed ID: 17187235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer.
    Tsubura A; Uehara N; Matsuoka Y; Yoshizawa K; Yuri T
    In Vivo; 2008; 22(2):191-201. PubMed ID: 18468403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis.
    Wood CE; Clarkson TB; Chen H; Veenstra TD; Xu X; Scott L; Cline JM
    Menopause; 2008; 15(5):890-8. PubMed ID: 18520696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Are breast density and bone mineral density independent risk factors for breast cancer?
    Harvey JA
    J Natl Cancer Inst; 2005 May; 97(10):778. PubMed ID: 15900048
    [No Abstract]   [Full Text] [Related]  

  • 37. Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology.
    Rebbeck TR; Troxel AB; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Norman S; Bunin G; DeMichele A; Berlin M; Schinnar R; Berlin JA; Strom BL
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):444-50. PubMed ID: 17372239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
    Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S
    Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer.
    Okoh V; Deoraj A; Roy D
    Biochim Biophys Acta; 2011 Jan; 1815(1):115-33. PubMed ID: 21036202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of estrogen carcinogenesis.
    Yager JD; Liehr JG
    Annu Rev Pharmacol Toxicol; 1996; 36():203-32. PubMed ID: 8725388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.